A Uk Based Cost-Effectiveness Analysis Of Glycopyrronium Bromide A New Anti-Muscarinic Agent For The Maintenance Treatment Of Patients With COPD

被引：0
|
作者：
Malcolm, W. A. [1 ]
Keyzor, I. [1 ]
Radwan, A. [1 ]
Price, D. B. [2 ]
Asukai, Y. [3 ]
Ananthapavan, J. [3 ]
机构：
[1] Novartis Pharmaceut, Frimley, England
[2] Univ Aberdeen, Aberdeen, Scotland
[3] IMS Hlth, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2156
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD
    Chan, Ming-Cheng
    Tan, Elise Chia-Hui
    Yang, Ming-Chin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 1079 - 1088
  • [2] COST-EFFECTIVENESS ANALYSIS OF UMECLIDINIUM BROMIDE COMPARED TO TIOTROPIUM BROMIDE FOR SYMPTOMATIC PATIENTS WITH COPD IN THE UK
    Ismaila, A.
    Roberts, G.
    Punekar, Y. S.
    O'Leary, M.
    VALUE IN HEALTH, 2014, 17 (07) : A595 - A595
  • [3] Cost-Effectiveness of Umeclidinium/Vilanterol Versus Indacaterol/Glycopyrronium in Symptomatic patients with COPD in the UK
    Ismaila, Afisi S.
    Shah, Dhvani
    Martin, Alan
    Kendall, Robyn
    Noorduyn, Stephen
    Dasari, Priyadarsini
    Risebrough, Nancy A.
    Compton, Chris
    Noorduyn, Stephen G.
    Risebrough, Nancy A.
    Compton, Chris
    Noorduyn, Stephen G.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] COST-EFFECTIVENESS ANALYSIS OF GLYCOPYRRONIUM BROMIDE IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN
    Torres, C.
    Betoret, I
    Sabater, E.
    Figueras, M.
    Casado, M. A.
    VALUE IN HEALTH, 2013, 16 (07) : A372 - A372
  • [5] Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China
    Gong, Shiyi
    Hu, Hao
    Zhao, Kun
    Yang, Ting
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 433 - 441
  • [6] COST-EFFECTIVENESS ANALYSIS OF INDACATEROL/GLYCOPYRRONIUM (IND/GLY) VS SALMETEROL/FLUTICASONE (SFC) AS MAINTENANCE TREATMENT FOR COPD PATIENTS IN TAIWAN: UPDATED BASED ON THE RESULTS OF THE FLAME STUDY
    Tan, E. C. H.
    Yang, M. C.
    VALUE IN HEALTH, 2019, 22 : S352 - S352
  • [7] COST-EFFECTIVENESS OF GLYCOPYRRONIUM COMPARED TO TIOTROPIUM IN COPD PATIENTS FROM A SWEDISH SOCIETAL PERSPECTIVE
    Costa-Scharplatz, M.
    Tambour, M.
    Henriksson, F.
    Stallberg, B.
    VALUE IN HEALTH, 2013, 16 (07) : A371 - A372
  • [8] The cost-effectiveness of physical activity in the management of COPD patients in the UK
    Ramos, Mafalda
    Lamotte, Mark
    Gerlier, Laetitia
    Svangren, Per
    Cases, Anna Miquel
    Haughney, John
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [9] Cost-effectiveness of physical activity in the management of COPD patients in the UK
    Ramos, Mafalda
    Lamotte, Mark
    Gerlier, Laetitia
    Svangren, Per
    Miquel-Cases, Anna
    Haughney, John
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 227 - 239
  • [10] Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden
    Madlaina Costa-Scharplatz
    Björn Ställberg
    Pankaj Goyal
    Yumi Asukai
    Jean-Bernard Gruenberger
    David Price
    Applied Health Economics and Health Policy, 2015, 13 : 637 - 645
12345